Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Novo Nordisk, a competitor of Eli Lilly, manufactures GLP-1 drugs Wegovy and Saxenda
The drug has been available on the NHS since 2018 to those with treat diabetes and has just been approved as a weight-loss aid, in what experts say is a pivotal moment in the fight against obesity
Efficacy and Safety of Dulaglutide Monotherapy Compared With Glimepiride in East-Asian Patients With Type 2 Diabetes in a Multicentre, Double-Blind, Randomized, Parallel-Arm, Active Comparator, Phase III Trial
Zepbound (tirzepatide) injection [Prescribing information]
doi: 10.1016/j.jff.2021.104812 175
US$ 22.84
US$ 26.62
US$ 25.50
US$ 29.86
US$ 29.24
